Using MRI to predict rectal cancer response to pre-surgery treatment
Part of Cancer, Digestive system clinical trials.
This study uses MRI scans to try to predict whether your rectal cancer completely disappears after pre-surgery chemoradiotherapy. The goal is to better personalize treatment decisions, possibly helping some patients avoid surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed diagnosis of locally advanced rectal cancer.
- You must have completed, or be about to receive, chemoradiotherapy (chemotherapy and radiation) before surgery.
- After your pre-operative treatment, you must be eligible for either surgery to remove the tumor or a 'watch-and-wait' approach (delaying surgery).
- You must be willing to sign a consent form and be covered by French health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patterns in the gut microbiome (gut bacteria) and gut chemicals (metabolites) to predict how rectal cancer may do after planned surgery. By understanding these markers, researchers hope to better forecast prognosis and tailor follow-up.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This study looks at whether a special scan called PET-MRI can better show how rectal cancer responds to treatment given before surgery. If it works well, it could help doctors plan the right next steps after chemoradiotherapy.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
This study uses special MRI scans taken before and during immunotherapy to see if the cancer is truly growing or just appearing to grow, which is called 'pseudoprogression'. It helps doctors better understand how well the treatment is working for rectal cancer.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.